Evaluating the Effectiveness of a Cognitive Behavioral Intervention (CBI)
Clinical Study to Evaluate the Effectiveness of a Cognitive Behavioral Intervention (CBI) Adjunctive to a Smart Powered Toothbrush on the Oral Health of Adolescents
1 other identifier
interventional
150
1 country
1
Brief Summary
This is a Phase III, randomized, one-center, three arm parallel group, open label and single blind clinical study to evaluate the effectiveness of a cognitive behavioral intervention (CBI) adjunctive to a smart powered toothbrush on the oral health of adolescents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2023
CompletedFirst Posted
Study publicly available on registry
March 23, 2023
CompletedStudy Start
First participant enrolled
August 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedApril 29, 2025
April 1, 2025
8 months
March 2, 2023
April 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gingival inflammation
A Löe-Silness Gingival Index score from 0 to 3 will be assigned by the examining dentist to all scorable surfaces of the maxillary and mandibular teeth using a dental light and dental mirror. A whole mouth mean score for each subject will be determined by adding the values given by the examining dentist to each scorable surface and dividing that number by the total number of surfaces scored. Scores Criteria 0 Absence of inflammation 1. Mild inflammation- Slight change in color and mild edema with little change in texture. No bleeding on probing. 2. Moderate inflammation- moderate glazing, redness, edema and hypertrophy. Bleeding on probing. 3. Severe inflammation- Marked redness, hypertrophy, edema and ulceration. Tendency for spontaneous bleeding.
All outcomes will be measured at baseline, at1 month, 3 months and at 6 months
Secondary Outcomes (4)
Plaque scores
All outcomes will be measured at baseline, 1 month, 3 months and at 6 months
Knowledge assessment
All outcomes will be measured at baseline, 1 month, 3 months and at 6 months
Efficacy assessment
All outcomes will be measured at baseline, 1 month, 3months and at 6 months
Motivation assessment
All outcomes will be measured at baseline, 1 month, 3months and at 6 months
Study Arms (3)
Test Group I
EXPERIMENTALA commercially available fluoride toothpaste (1450 ppm F) A commercially available Smart Electric toothbrush Cognitive behavioral intervention (CBI)
Control group I
ACTIVE COMPARATORA commercially available fluoride toothpaste (1450 ppm F) A commercially available Smart Electric toothbrush
Control group II
NO INTERVENTIONA commercially available fluoride toothpaste (1450 ppm F) A commercially available soft bristle toothbrush
Interventions
A six-session CBI Intervention component will be used with the TEST GROUP I. This will examine a cognitive behavioral intervention designed to improve tooth brushing and oral hygiene. The components include oral health education, values-based activities, motivational interviewing, goal setting, problem solving skills, cognitive restructuring, verbal reinforcement and stress management.
A Colgate smart toothbrush that provides the user with details on toothbrushing habits and frequency
Eligibility Criteria
You may qualify if:
- Students are enrolled in participating high schools Caregivers give informed consent Student gives assent
You may not qualify if:
- Having a prosthetic heart valve
- Having a history of previously having infective endocarditis
- Having had joint replacement surgery
- Children on blood thinner medication such as Coumadin or Rivaroxaban
- Children who are currently receiving chemotherapy
- Children who have received organ transplants of any type
- Children with Leukemia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Howard Universitylead
- Temple Universitycollaborator
Study Sites (1)
Friendship Public Charter School
Washington D.C., District of Columbia, 20059, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 2, 2023
First Posted
March 23, 2023
Study Start
August 6, 2023
Primary Completion
April 6, 2024
Study Completion
February 28, 2025
Last Updated
April 29, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual data available to other researchers